RESULTS: Both Rejuvesol and PAGGGM treatment produced increased adenosine triphosphate and total adenylate and 2,3-diphosphoglycerate levels compared with untreated red blood cell concentrates. Regardless of prefreeze Rejuvesol or PAGGGM treatment, postthaw hemolysis remained below 0.8% during 7 days in SAGM and during 35 days in AS-3. At Day 35 of postthaw storage in AS-3, total adenylate in nonrejuvenated red blood cell concentrates had decreased to 72% of the original values; whereas, in prefreeze Rejuvesol-treated and PAGGGM-treated concentrates, adenylate values were still were at 101% and 98%, respectively.
CONCLUSION:
Based on maximum allowable hemolysis of 0.8% and total adenylate content greater than 82% of the original value, thawed, prefreeze Rejuvesol-treated or PAGGGM-treated red blood cell concentrates can be stored for 35 days at 2 to 6 C in AS-3.
F
reezing red blood cells (RBCs) enables preservation for a period of at least 10 years. 1 After the mandatory deglycerolization procedure, such cells can be stored for another 14 days at 2 to 68C in additive solution formula 3 (AS-3), if processed in a fully closed system. [1] [2] [3] At these temperatures, the cell's metabolism is depressed but not stopped, so inevitably the detrimental effects of storage will start to appear at some point in time. During storage, RBCs undergo a series of biochemical and morphologic changes, which adversely affect their primary role to take up, transport, and deliver oxygen to tissues at the microcirculatory level. This complex of changes, which is particularly prominent after 14 days of storage and onward, 4 has a strongly interdependent character and is commonly referred to and known as the "storage lesion."
The biochemical changes include a progressive loss of 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP), as well as a buildup of lactic acid and oxidative damage to the RBC membrane's lipids, proteins, and carbohydrates. 5 Also, an increased presence of phosphatidylserine is found on the outer leaflet of the RBC membrane. The morphologic changes comprise a transition from biconcave discs, to echinocytes, and finally to spheres, 7 accompanied by a shedding of microvesicles. 8 One of the consequences of the "storage lesion" is that damage to the membrane and loss of lipids from that membrane, including the formation of vesicles, lead to a less favorable surface-to-volume ratio. 9 This has a negative effect on the RBC's deformability, which is necessary to survive repeated passages through the narrowest capillaries with a diameter about one-half that of a normal RBC. 9 Thus, it will also reduce the cell's survival after transfusion. 10 Biochemical modification, also called rejuvenation, is a method known to restore the RBC ATP and 2,3-DPG contents to normal or even supranormal levels. 11 It will also restore, at least partially, the shape change from spherocytes and echinocytes back to discs, 12 improve oxygen delivery 13 as well as the membrane's elasticity, 14 and reverse poststorage RBC adhesion to endothelial cells. 15 The concept of rejuvenation, using solutions that contain pyruvate, inosine, phosphate, and adenine with or without glucose (PIGPA and PIPA, respectively) has been developed and successfully used, mainly to prevent discarding of outdated RBCs, 16, 17 but it has also been advocated as being important in specific clinical situations, such as patients in hemorrhagic shock 11 and those undergoing cardiopulmonary bypass, for example. 18 Other than the costs and the prestorage labor, the downside of this procedure is that rejuvenated RBCs need to be washed before transfusion because of the potential toxicity of the metabolites of inosine and adenine in the rejuvenation solution. 11 However, when applied to RBCs meant to be frozen in glycerol, this downside is relative, because these cells already need a mandatory postthaw washing procedure before transfusion to bring the residual glycerol concentration down to less than 1% (weight/volume) 19 to avoid hemolysis in the patient's circulation.
In an earlier study, 20 we confirmed the findings of List and colleagues 21 that omitting the prefreeze centrifugation step after glycerolization prolongs the postthaw shelf life of previously frozen RBCs in saline-adenine-glucosemannitol (SAGM) even considerably more if combined with the use of phosphate-buffered saline as an alternative washing solution and AS-3 as the final storage medium. 22 The primary aim of the current study was to determine whether the combination of the previous modifications and the use of RBCs with improved "in vitro" characteristics-specifically regarding ATP and 2,3-DPG content before freezing with the high glycerol method (40%)-could even further extend the postthaw shelf life of these cells.
For this purpose, before freezing, RBCs were rejuvenated using a PIPA solution (Rejuvesol) in one arm of the study (further referred to as prefreeze Rejuvesol [pf-R]); and, in the other arm, RBCs were stored prefreeze in the recently developed RBC additive solution phosphateadenine-glucose-guanosine-gluconate-mannitol (PAGGGM) (further referred to as prefreeze PAGGGM [pf-PAGGGM]), which was designed to better maintain metabolic status during storage (Table 1) . 23, 24 In both arms of the study, we compared postthaw stability and quality after resuspension in AS-3 and SAGM.
MATERIALS AND METHODS

Study design
Four units of leukoreduced RBCs in SAGM were stored at 2 to 68C. At Day 8 after collection, the four units were pooled, mixed, and split. Of these units, two were rejuvenated according to the manufacturer's protocol. Within 1 hour after rejuvenation, all four units were glycerolized, frozen, and stored for at least 2 weeks at 2808C. After thawing and deglycerolization, one unit from each pair was resuspended in SAGM, and one was resuspended in AS-3. In addition, two units of leukoreduced RBCs in PAGGGM were stored at 2 to 68C. At Day 8 after collection, the units were pooled, mixed, and split. Both units were subsequently glycerolized, frozen, and stored for at least 2 weeks at 2808C. After thawing and deglycerolization, one unit was resuspended in SAGM, and one was resuspended in AS-3. This sequence was repeated three times over the following days for the leukoreduced SAGM and PAGGGM units.
Thus, the postthaw study in one arm comprised eight units treated with Rejuvesol (originally stored in SAGM), of which four were resuspended in AS-3 and four were resuspended in SAGM, and eight nonrejuvenated units (originally stored in SAGM), of which four were resuspended in AS-3 and four were resuspended in SAGM. The other arm of the postthaw study comprised eight units (originally stored in PAGGGM), of which four were resuspended in AS-3 and four were resuspended in SAGM. The design and the time frame of the study from collection to postthaw storage is depicted in Fig. 1 . (n 5 4), mixed, and split. From each pool, two units were incubated with Rejuvesol before freezing. All units were glycerolized within 1 hour after rejuvenation, frozen, stored for at least 14 days at 2808C, and deglycerolized. From each pair, one unit was resuspended in SAGM, and the other was suspended in AS-3. All thawed units were subsequently stored at 2 to 68C for at least 35 days. Series II: At Day 8 after collection, two units of RBCs in PAGGGM were pooled (n 5 4), mixed, and split. All units were then glycerolized, frozen, stored for at least 14 days at 2808C, and deglycerolized. From each pair, one unit was resuspended in SAGM, and the other was suspended in AS-3. All thawed units were subsequently stored at 2 to 68C for at least 35 days.
Blood collection and processing
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0 of the study. The whole blood units were placed on butane-1,4-diol cooling plates (Compocool; FreseniusKabi) to allow temperature adjustment to 20 to 248C. 25 After an overnight hold, the whole blood units were processed according to the routine buffy coat procedure, as previously described. 26 Briefly, after a hard spin (Sorvall RC12BP), the whole blood units were separated in components using an automated blood component separator (Compomat G5; Fresenius HemoCare). After separation, 110 mL of additive solution, SAGM, or PAGGGM was added to the RBCs through the filter. After careful mixing, the units were white blood cell-reduced using an inline leukoreduction filter (BioR; Fresenius-Kabi). The RBC units were subsequently stored at 2 to 68C for 7 days before rejuvenation (if applicable), glycerolization, and freezing.
Rejuvenation
The rejuvenation procedure with Rejuvesol (Citra Labs) was carried out according to the instructions of the manufacturer. Units meant to be rejuvenated were incubated in a water bath, maintained at 378C, for 60 minutes in 50 mL of Rejuvesol containing 0.550 g sodium pyruvate, 1.340 g inosine, 0.034 g adenine, 0.730 g dibasic sodium phosphate, and 0.311 g monobasic sodium phosphate (in water for injection, with an osmolality of 510 mOsm/kg H 2 O; pH 6.7-7.4) ( Table 1) .
Glycerolization
RBC units were centrifuged at 3200 3 g for 5 minutes. The additive solution was removed to produce RBC units with a hematocrit (Hct) of 75 6 5%. The RBC units were sterilely connected (TSCD; Terumo-BCT) to a disposable glycerolization set (LN225; Haemonetics), and glycerolization was completed using the ACP215. A volume of 6.2 mol/L (57%) glycerol solution (SALF SpA) was added to the RBCs to achieve a final glycerol concentration of 40% (weight/ volume). The glycerolized cells were transferred to a 1000-mL polyvinyl chloride bag (VSE 6002Z; MacoPharma), and the RBC units were sealed in a plastic overwrap and frozen, as described before. 27 All frozen RBC units were stored at 2808C for at least 14 days.
Thawing, deglycerolization, and storage
The frozen RBCs were thawed in a water bath maintained at 408C to achieve a surface temperature of 25 to 308C, as measured with a noncontact thermometer (Fluke 62 Mini;). The thawed RBC units were sterilely connected to a deglycerolization set (LN235; Haemonetics) and washed in ACP215 using 50 mL of 12% NaCl (Bio-Deglyc) followed by several rounds of washing with a total of 1.6 liters of phosphate-buffered saline, pH 7.4. 22 Upon completion of the deglycerolization process, the cells were washed with and finally resuspended in either SAGM or AS-3 (both from Haemonetics). The plan was to store the deglycerolized RBC units at 2 to 68C for at least 35 days. The efficacy of the deglycerolization procedure was assessed by measuring the supernatant osmolality 28 using an Osmomat 030-D Cryoscopic osmometer (Gonotec) immediately after the deglycerolization procedure.
Hematologic parameters and recovery
The volume of the blood components was calculated from the net weight divided by the specific gravity: 1.027 g/mL for plasma, 1.100 for 40% glycerol and RBCs, and 1.006 for SAGM. Using the hematocrit of the solution, the specific gravity of RBCs in additive solution was calculated from these values. Freeze-thaw-wash recovery was calculated by comparing total hemoglobin (Hb) levels after deglycerolization with total Hb levels before glycerolization. Total Hb was calculated as volume (in liters) 3 Hb concentration (g/L). Hb concentrations and RBC count were determined on a hematology analyzer (Advia 2120; Siemens Medical Solutions Diagnostics). Hct was measured with the spun capillary method. Hemolysis was determined as described previously. 23 Briefly, cell-free supernatants were obtained by centrifugation of the RBC suspensions at 12000 3 g for 5 minutes followed by an additional centrifugation of the supernatant at 12,000 3 g for 30 seconds. The centrifugation protocol used was checked upon loss of microparticles (formed during storage) from the supernatant. It was found that microvesicles were not significantly removed. Free Hb was determined by absorbance measurement of supernatant at 415 or 514 nm by a spectrophotometer (Eon plate reader; Bio Tek), with correction for plasma absorption if necessary. Hemolysis was expressed as the percentage of total Hb present in the RBCs after correction for Hct.
Analysis of metabolic and cellular variables
Extracellular potassium, glucose, lactate, and pH were measured with a blood gas analyzer (Rapidlab 1265; Siemens Medical Solutions Diagnostics). 2,3-DPG and adenine nucleotides (ATP, adenosine diphosphate [ADP], and adenosine monophosphate [AMP]) levels were determined in neutralized perchloric acid extracts. 2,3-DPG was analyzed with an enzymatic assay from Roche, and adenine nucleotides were assayed using a high-performance liquid chromatography method. 29 The measured concentrations (mmol/L) were divided by the Hb concentration (g/L). Values for 2,3-DPG and adenine nucleotides are thus expressed in mmol/g Hb. Total adenylate content was calculated as the sum of ATP, ADP, and AMP levels
Phosphatidylserine exposure
To quantify the amount of RBCs that exposed phosphatidylserine (PS) on the cell surface, cells were stained with fluorescein isothiocyanate-labeled Annexin V, essentially according to Verhoeven and colleagues. 6 Briefly, samples of RBCs were washed twice with an incubation medium consisting of 134 mM NaCl, 10 mM glucose, 10 mM Tris-HCl, 40 mM sucrose, 20 mM HEPES, and 0.5% human serum albumin, pH 7.4. After washing, the cells were resuspended at 0.3% Hct in the same medium supplemented with 2.5 mM CaCl 2 . Labeling with Annexin V was performed by adding Annexin V-fluorescein isothiocyanate (VPS-Diagnostics) to a final concentration of 1 mg/mL to 250 mL cell suspension. After incubation at room temperature in the dark for 30 minutes, the cells were washed once and analyzed on a flow cytometer (LSRII; Becton Dickinson). The percentage of Annexin V-positive cells was determined by comparison with a negative control that was incubated with ethylene glycol tetraacetic acid.
Deformability
The deformability of an RBC is an indication of its capability to deform during its passage through the narrowest capillaries of the microcirculation and thus indicates its capacity to survive after transfusion. Expressed as the deformation index (DI), deformability was defined as the ratio of the major axis length to the minor axis width. Thus, the DI of a disc-shaped RBC, by definition, is equal to 1. The DI was determined with an Automated Rheoscope and Cell Analyzer (ARCA; Mechatronics Instruments). 30 In short, a thin layer of RBCs is sheared between two horizontal plates, one of which is able to rotate with variable speed at an adjustable distance from the other. These variables lead to a variable, deforming force exerted on the RBCs. An increasing force results in elongation (deformation) of the RBC in the resulting current. This process is measured by a laser-beam diffraction pattern, which is captured on a video camera and analyzed by a computer on an individual cell basis. Results are expressed as the percentage of cells with a DI less than 1.5 (nondeformable cells) and those with a DI greater than 2.5 (deformable cells).
Statistical analysis
The results are shown as means 6 standard deviations. 
RESULTS
Effects of Rejuvesol and PAGGGM
Compared with control units, pf-R units had increased ATP levels in RBCs stored for 7 days in SAGM, from 5.5 6 0.1 mmol/g Hb to 7.5 6 0.3 mmol/g Hb (a mean increase of 36%) ( Table 2 ), partly at the expense of ADP levels (which decreased from 0.84 6 0.12 to 0.30 6 0.02 mmol/g Hb). Total adenylate levels rose from 6.5 6 0.1 mmol/g Hb to a mean of 8.2 6 0.2 mmol/g Hb (a mean increase of 27%) in the pf-R units (Table 2 ). In the pf-PAGGGM units, we measured mean ATP and mean total adenylate contents of 6.2 6 0.4 mmol/g Hb and 6.8 6 0.3 mmol/g Hb, respectively, indicating a small positive effect compared with the (nonrejuvenated) control units in SAGM ( Table 2) . Levels of 2,3-DPG in the pf-R units climbed from 4.6 6 2.1 mmol/g Hb to 22.7 6 1.7 mmol/g Hb (a mean increase of almost 400%). The pf-PAGGGM units showed 2,3-DPG levels of 14.7 6 1.6 mmol/g Hb (Table 2) .
Freezing, thawing, and deglycerolization characteristics
Hb contents of the RBC units before freezing were comparable, indicating efficient pooling and splitting. Volumes of the rejuvenated RBCs were higher because of the addition of Rejuvesol (Table 2) .
After thawing, the volume of all units was approximately 300 mL with an Hb content of approximately 40 g. The freeze-thaw-wash recovery was around 80%, with no difference between the different groups ( Table 2) .
Hct of the thawed units depended on the additive solution used and was higher in AS-3 units compared with SAGM units. In addition, pH depended on the additive solution and was lower in AS-3 units than in SAGM units (Tables 1 and 2 ).
The osmolality of the supernatant in all 24 deglycerolized units was well below 420 mOsm/kg and was comparable for the three groups (Table 2) , indicating adequate removal of glycerol (with remaining glycerol levels less than 1%). 1, 19 The osmolality of the supernatant of the SAGM units was considerably higher than of the AS-3 units (Table 2 ) because of the difference in osmolality of these two additive solutions (Table 1) .
Postthaw storage characteristics Hemolysis
The units stored in SAGM had clearly higher hemolysis levels than those stored in AS-3 (Fig. 2) . As early as Day 14 of postthaw storage in SAGM, hemolysis reached levels above the 0.8% (European) threshold. In AS-3 units, postthaw hemolysis remained below 0.8% for at least 35 days. Because of the favorable results obtained with AS-3, the measurements in AS-3 units were continued until Day 42 ( Figs. 2-4) . Prefreeze rejuvenation or incubation in PAGGGM had no influence on postthaw hemolysis.
ATP and total adenylate
Immediately after thawing, ATP levels were increased in both the pf-R and pf-PAGGGM units (Fig. 3) . During storage, ATP levels gradually decreased, with a faster decrease observed in the pf-R units. During postthaw storage in SAGM, ATP levels in pf-R units remained significantly higher than those in the nonrejuvenated cells during the first 2 weeks of storage only; whereas, in the pf-PAGGGM units, ATP levels were higher during 35 days of storage. In AS-3, ATP-levels of both pf-R and pf-PAGGGM were significantly higher than those of the (non-rejuvenated) control cells for 35 days. Total adenylate levels were increased by the treatment with Rejuvesol before freezing and remained significantly higher than the levels in control units during the whole postthaw storage time, in both SAGM and AS-3 (Fig. 4) . The same was true for cells prefreeze stored in PAGGGM. At the end of the storage period (Day 35 in SAGM, Day 42 in AS-3), total adenylate levels in pf-R and pf-PAGGGM units were comparable or even slightly higher compared with the levels in (nonrejuvenated) control cells immediately after thawing (Fig. 4) .
2,3-DPG
During the first 2 weeks of postthaw storage, 2,3-DPG levels in pf-R and pf-PAGGGM units were significantly higher compared with the levels in control cells, with only small differences observed between storage in SAGM and AS-3 (Fig. 5) . At Day 21 of storage, 2,3-DPG levels in all units were near the limit of detection. Despite the higher initial levels in pf-R units, at Day 14 of storage, the levels were comparable for pf-PAGGGM and pf-R.
PS exposure and deformability
At Day 35 of storage, the percentage of Annexin V-positive cells amounted to 4.7 6 1.6% in SAGM and was significantly higher (7.9 6 2.5%) when stored in AS-3 (Table 3) . PS exposure was not influenced by pf-R or pf-PAGGGM, regardless of the postthaw additive solution. Deformability was measured at Day 35 of postthaw storage. pf-PAGGGM units had a higher percentage of nondeformable cells (DI < 1.5) and a lower percentage of deformable cells (DI > 2.5) compared with control or pf-R units. This effect was significantly more pronounced during storage in AS-3 compared with storage in SAGM. For the control and pf-R units, there were no significant differences between storage in AS-3 and SAGM ( 
Supernatant osmolality (n 5 12), mOsm/kg 302 6 3* pH at 378C (n 5 12) 6.49 6 0.03* *p < 0.05 compared with SAGM.
postthaw shelf life, while still meeting all previous requirements, would simplify frozen RBC inventory management by limiting unnecessary wastage and shortages, from which both civilian and military transfusion practice could benefit. Hemolysis and energy status are of particular importance when considering the possibilities of extending the currently approved shelf life. Previous adjustments in the glycerolization and washing procedure 20, 22 helped to achieve a postthaw shelf life of 28 days in AS-3. Although hemolysis remained below 0.8% for as many as 35 days, the energy status, as measured by the total adenylate content, proved to be the limiting factor. ATP content is indirectly related to posttransfusion survival, because normal ATP levels are necessary to prevent membrane loss by microvesiculation and also to maintain active, outward transport of phospholipids like PS, thus preventing premature clearance from the recipient's circulation by macrophages. 33 Rejuvesol and the recently developed alkaline, chlorine-free additive solution PAGGGM 23, 24 are known to be able to increase ATP (and also 2,3-DPG) levels. The inosine and adenine in Rejuvesol are the key factors in raising the levels of 2,3-DPG and ATP, respectively, through the Embden-Meyerhof (glycolytic) pathway. 34 Most likely, PAGGGM has a positive effect on the activity of phosphofructokinase in the glycolytic pathway, thus raising the levels of both ATP and 2,3-DPG. 24 Prefreeze rejuvenation of RBCs stored for 7 days at 2 to 68C in SAGM and, to a lesser extent, the replacement of SAGM by PAGGGM resulted in significantly higher levels of 2,3-DPG, ATP, and total adenylate ( Table 2 ). These increased levels were maintained during the frozen storage and deglycerolization procedures.
Although ATP levels were better maintained during postthaw storage in SAGM compared with storage in AS-3, SAGM failed to keep hemolysis below 0.8% after 7 days in all units (Fig. 2A) . If resuspended in AS-3, however, for both (nonrejuvenated) control, pf-R, and pf-PAGGGM units, hemolysis stayed below the threshold of 0.8% for up to 35 days, with no differences between the groups (Fig.  2B ). This lower hemolysis in AS-3 compared with SAGM appears to be completely attributable to its citrate content, 22, 35 which not only confirms our earlier results with regard to hemolysis 20, 22 but also confirms the superiority of AS-3 as a long-term storage medium for deglycerolized RBCs.
During postthaw storage, the ATP levels gradually declined, accompanied by an increase in the levels of ADP and AMP. In the glycolytic pathway, both AMP and ADP can be converted back to ATP, so both substances still contribute to the cell's energy status, expressed as the total adenylate content. Only when AMP is converted to inosine monophosphate, which is irreversible for RBCs, is the potential to recover ATP lost; however, no increase in inosine monophosphate was observed (data not shown). US and European guidelines dictate an "in vivo," 24-hour posttransfusion survival of at least 75%. 1, 3, 32 As a surrogate marker for 'in vivo' survival, total adenylate content could be used. H€ ogman and colleagues 36 not only found a good correlation between total adenylate content and posttransfusion recovery but also observed that the minimum total adenylate content needed to meet this requirement was 82% of the original levels. Whereas (nonrejuvenated) control units failed to meet this requirement at Day 35, all pf-R and pf-PAGGGM units had total adenylate levels above this level, independent of the additive solutions used for postthaw storage (results not shown). So, in contrast to our earlier study in which total adenylate content limited the postthaw storage, 20 hemolysis was the limiting factor in pf-R and pf-PAGGGM units during postthaw storage in AS-3. Not surprisingly, because of the 7 days of storage, the (nonrejuvenated) control units had 2,3-DPG levels that already were close to zero before freezing (Fig. 5) . During the first 14 days of postthaw storage in both SAGM and AS-3, pf-R and pf-PAGGGM units had significantly higher levels of 2,3-DPG (Fig. 5) , suggesting better oxygen delivery capacity, from which certain patients may benefit. 11, 18, 23 Levels of 2,3-DPG at Day 7 in both SAGM and AS-3 were still comparable to those in fresh RBCs at the beginning of routine (refrigerated) blood bank storage at 2 to 68C. 5 We postulate that the acidic postthaw environment, caused by SAGM and even more by AS-3, quickly neutralized the favorable effect of Rejuvesol and PAGGGM on 2,3-DPG levels during storage. As early as Day 0, the pH in all units was well below the turning point of 7.2 (Table 2) , at which bisphosphoglycerate phosphatase is activated, 37 causing a rapid loss of 2,3-DPG. 38 At the same time, because of the lower pH of SAGM and AS-3, the prevailing effect of bisphosphoglycerate mutase on the RapoportLuebering shunt sustains the production of ATP farther down the glycolytic pathway. This would explain the longer lasting effect of Rejuvesol and PAGGGM on ATP levels in the deglycerolized units. Storage of leukoreduced RBCs in routine refrigerated blood banking shows very low levels of PS exposure, as measured by the number of Annexin V-positive cells, even after 35 days. 6 Cryopreservation by itself does not cause PS exposure. 39 The higher percentages of PS exposure we observed at Day 35 in all units may be attributable in part to the longer prefreeze storage time 39 ; however, especially for the AS-3 units, the lower pH of approximately 6.49 (Table 2 ) could be responsible. 40 Deformability is strongly related to normal RBC function and RBC viability 41 43 Although speculative, based on the total adenylate content and its predictive value considering 24-hour posttransfusion survival, deformability defects may very well be restored upon transfusion, thus limiting possible negative rheologic effects at the microcirculatory level. The rather long prefreeze storage time of 7 days, which was chosen for logistical reasons, as well as the low pH of AS-3 have most probably negatively influenced the outcome of this study, particularly with regard to 2,3-DPG, because this substance is strongly affected by length of prefreeze storage at 48C. 39, 44 Furthermore, maintaining a physiologic intracellular pH of approximately 7.4 by at least raising the pH of the final resuspension medium in particular, with citrate as an important constituent, would also potentially help to improve future results. Even better results probably may be obtained by performing the whole procedure from collection to postthaw storage at alkaline levels, as proposed in earlier studies on processing and storage of liquid RBCs. 23, 24, 38, 45, 46 In this respect, PAGGGM, with its pH of 8.0, could be the additive solution of choice. Currently, PAGGGM is not Conformit e Europ eene marked but is only designed and used for research purposes. Further research on the use of PAGGGM as an additive solution is planned, including "in vivo" evaluation of RBCs stored in PAGGGM. However, because the presence of citrate seems to be necessary for maintaining postthaw stability, PAGGGM cannot be used for long-term storage of thawed cells. A PAGGGM-based solution with (part of) the mannitol replaced by citrate might produce both the desired postthaw stability and high levels of intracellular organic phosphate compounds.
In conclusion, our current findings indicate the possibility of extending the postthaw shelf life of RBCs, either rejuvenated with Rejuvesol or prefreeze stored in PAGGGM, to at least 35 days. The important practical implication of this study is that it facilitates operating a frozen blood bank, by minimizing the effects of a timeconsuming deglycerolization procedure. Thus, the ability to maintain a liquid, previously frozen inventory of RBCs creates the possibility to better meet unexpected operational demands, as is the case under battle field conditions e.g. Operational and logistical advantages may thus very well outweigh the higher cost of maintaining and operating a frozen blood bank, including the additional cost of using Rejuvesol or PAGGGM.
